CBD Suppressed Immune Function by Disrupting a Key T Cell Signaling Pathway, Independent of Cannabinoid Receptors

CBD suppressed T cell function by deregulating NFAT and AP-1 transcription factors, and this immune suppression occurred even in mice completely lacking both CB1 and CB2 cannabinoid receptors.

Kaplan, Barbara L F et al.·Biochemical pharmacology·2008·Moderate EvidenceAnimal StudyAnimal Study
RTHC-00315Animal StudyModerate Evidence2008RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Building on previous findings that CBD suppresses IL-2 production, researchers investigated the mechanism and found CBD has broad immunosuppressive effects on T cells.

CBD suppressed production of IL-2 and IFN-gamma (key immune signaling molecules), inhibited T cell proliferation, reduced surface expression of the activation marker CD25, and suppressed antibody production in response to a standard immune challenge.

The mechanism involved suppression of two critical transcription factors: AP-1 and NFAT, which are essential regulators of T cell activation and cytokine production.

Critically, these immunosuppressive effects persisted in splenocytes from mice completely lacking both CB1 and CB2 receptors, proving CBD's immune effects operate through an entirely different pathway than traditional cannabinoid signaling. However, the CB1/CB2 knockout mice had a generally weaker immune response, showing these receptors do play a role in baseline immune function.

Key Numbers

CBD suppressed IL-2 and IFN-gamma production, CD25 expression, T cell proliferation, and anti-sRBC IgM antibody responses. Effects persisted in CB1/CB2 double-knockout mice. AP-1 and NFAT transcriptional activity were suppressed.

How They Did This

Murine splenocytes and purified T cells were treated with CBD and assessed for cytokine production, proliferation, surface marker expression, and antibody responses. Transcription factor activity was measured. CB1/CB2 double-knockout mice were used to determine receptor involvement.

Why This Research Matters

This study identified a specific molecular mechanism for CBD's immune suppression (NFAT/AP-1 deregulation) and proved it doesn't require either known cannabinoid receptor. This has implications for autoimmune disease treatment but also raises questions about whether regular CBD use could compromise immune function.

The Bigger Picture

This study provided one of the clearest molecular mechanisms for CBD's immunosuppressive effects and definitively showed these effects don't work through cannabinoid receptors. The NFAT pathway is also targeted by cyclosporine, a powerful immunosuppressant used in organ transplantation, placing CBD's immune effects in a clinically relevant context.

What This Study Doesn't Tell Us

In vitro mouse immune cell studies may not predict human immune responses. The CBD concentrations used may not reflect achievable human tissue levels. Only acute exposure was examined.

Questions This Raises

  • ?Could CBD's NFAT suppression be therapeutically exploited for autoimmune conditions?
  • ?Does regular oral CBD use in humans measurably suppress immune function?
  • ?What is CBD's non-cannabinoid receptor target for these immune effects?

Trust & Context

Key Stat:
CBD suppressed T cells through NFAT, independent of both CB1 and CB2 receptors
Evidence Grade:
This is a well-designed mechanistic study using knockout mice to confirm receptor independence, providing moderate evidence for a specific CBD immune mechanism.
Study Age:
Published in 2008. CBD's non-cannabinoid receptor targets have been further investigated, with several additional molecular targets identified since.
Original Title:
The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT).
Published In:
Biochemical pharmacology, 76(6), 726-37 (2008)
Database ID:
RTHC-00315

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

What is NFAT?

Nuclear Factor of Activated T cells (NFAT) is a transcription factor essential for T cell activation and immune responses. It's the target of immunosuppressive drugs like cyclosporine and tacrolimus used to prevent organ transplant rejection.

Could CBD weaken my immune system?

This study showed CBD suppresses T cell function at the molecular level. However, in vitro concentrations may not reflect what happens in the human body after oral CBD. Whether typical CBD doses meaningfully affect human immunity remains an open question.

Read More on RethinkTHC

Cite This Study

RTHC-00315·https://rethinkthc.com/research/RTHC-00315

APA

Kaplan, Barbara L F; Springs, Alison E B; Kaminski, Norbert E. (2008). The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT).. Biochemical pharmacology, 76(6), 726-37. https://doi.org/10.1016/j.bcp.2008.06.022

MLA

Kaplan, Barbara L F, et al. "The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT).." Biochemical pharmacology, 2008. https://doi.org/10.1016/j.bcp.2008.06.022

RethinkTHC

RethinkTHC Research Database. "The profile of immune modulation by cannabidiol (CBD) involv..." RTHC-00315. Retrieved from https://rethinkthc.com/research/kaplan-2008-the-profile-of-immune

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.